UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies

International journal of molecular sciences, 2018-05, Vol.19 (5), p.1418

2018

Volltextzugriff (PDF)

New insights into pathogenesis point to HIV-1 Tat as a key vaccine target

Archives of virology, 2021-11, Vol.166 (11), p.2955-2974

2021

Volltextzugriff (PDF)

Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies

International journal of molecular sciences, 2022-02, Vol.23 (4), p.2081

2022

Volltextzugriff (PDF)

HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication

International journal of molecular sciences, 2020-12, Vol.22 (1), p.317

2020

Volltextzugriff (PDF)

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

Frontiers in immunology, 2019-02, Vol.10, p.233-233

2019

Volltextzugriff (PDF)

Identification of the hemangioblast in postnatal life

Blood, 2002-11, Vol.100 (9), p.3203-3208

2002

Volltextzugriff (PDF)

Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease

Vaccines (Basel), 2019-08, Vol.7 (3), p.99

2019

Volltextzugriff (PDF)

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART

EBioMedicine, 2021-04, Vol.66, p.103306-103306, Article 103306

2021

Volltextzugriff (PDF)

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

Nature medicine, 2002-03, Vol.8 (3), p.225-232

2002

Volltextzugriff (PDF)

Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome‐independent block of angiogenesis and matrix metalloproteinases

International journal of cancer, 2011-01, Vol.128 (1), p.82-93

2011

Volltextzugriff (PDF)

"cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies"

Expert review of vaccines, 2018-02, Vol.17 (2), p.115-126

2018

Volltextzugriff (PDF)

The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells

Angiogenesis (London), 2014-10, Vol.17 (4), p.831-838

2014

Volltextzugriff (PDF)

HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway

Molecular biology of the cell, 2006-04, Vol.17 (4), p.1985-1994

2006

Volltextzugriff (PDF)

Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12

Blood, 1999-03, Vol.93 (5), p.1612-1621

1999

Volltextzugriff (PDF)

ATL

International journal of gynecological cancer, 2013-11, Vol.23 (9), p.1663-1669

2013

Volltextzugriff (PDF)

Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor

Molecular biology of the cell, 2001-10, Vol.12 (10), p.2934-2946

2001

Volltextzugriff (PDF)

Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12

Journal of leukocyte biology, 1998-09, Vol.64 (3), p.384-392

1998

Volltextzugriff (PDF)

Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi’s Sarcoma

International Journal of Vascular Medicine, 2011-01, Vol.2011, p.452729-8

2011

Volltextzugriff (PDF)

Interferon-Inducible Protein-10 Identified as a Mediator of Tumor Necrosis in vivo

Proceedings of the National Academy of Sciences - PNAS, 1996-11, Vol.93 (24), p.13791-13796

1996

Volltextzugriff (PDF)

Mechanism of Paclitaxel Activity in Kaposi's Sarcoma

The Journal of immunology (1950), 2000-07, Vol.165 (1), p.509-517

2000

Volltextzugriff (PDF)

HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy

Expert review of vaccines, 2020-01, Vol.19 (1), p.71-84

2020

Volltextzugriff (PDF)

HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction

Molecular cancer therapeutics, 2020-12, Vol.19 (12), p.2476-2489

2020

Volltextzugriff (PDF)

Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth

The lancet oncology, 2003-09, Vol.4 (9), p.537-547

2003

Volltextzugriff (PDF)

Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly

Cancer research communications, 2024-08, Vol.4 (8), p.2112-2122

2024

Volltextzugriff (PDF)

Alpha Interferon Inhibits Human Herpesvirus 8 (HHV-8) Reactivation in Primary Effusion Lymphoma Cells and Reduces HHV-8 Load in Cultured Peripheral Blood Mononuclear Cells

Journal of Virology, 1999-05, Vol.73 (5), p.4029-4041

1999

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(76)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies

New insights into pathogenesis point to HIV-1 Tat as a key vaccine target

Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies

HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

Identification of the hemangioblast in postnatal life

Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome‐independent block of angiogenesis and matrix metalloproteinases

"cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies"

The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells

HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway

Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12

ATL

Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor

Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12

Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi’s Sarcoma

Interferon-Inducible Protein-10 Identified as a Mediator of Tumor Necrosis in vivo

Mechanism of Paclitaxel Activity in Kaposi's Sarcoma

HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy

HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction

Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth

Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly

Alpha Interferon Inhibits Human Herpesvirus 8 (HHV-8) Reactivation in Primary Effusion Lymphoma Cells and Reduces HHV-8 Load in Cultured Peripheral Blood Mononuclear Cells

Suchergebnisse filtern